Literature DB >> 15281414

Willingness and competence of depressed and schizophrenic inpatients to consent to research.

Bruce J Cohen1, Elizabeth L McGarvey, Relana C Pinkerton, Ludmila Kryzhanivska.   

Abstract

In this study, the willingness of psychiatric inpatients to volunteer for research and their capacity to consent to and distinguish between protocols offering different levels of risk and benefit were assessed. Twenty-two inpatients with major depressive disorder, 21 inpatients with schizophrenia, and 21 community control subjects were asked to consider participation in a lower-risk study offering the potential for direct medical benefit and a higher-risk study offering no direct medical benefit. Consent-related capacities were assessed with the MacArthur Competence Assessment Tool-Clinical Research. Depressed inpatients, while having a greater degree of impairment than control subjects, still demonstrated relatively high decision-making capacity and were able to distinguish levels of risk between studies. Their pattern of preferences did not differ from control subjects. However, they were more likely to decline to participate in the research, being six times more likely to decline the lower-risk study and 1.4 times more likely to decline the higher-risk study. Schizophrenic subjects demonstrated greater impairments in decision-making capacity and were even more likely than depressed subjects to decline to participate.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach; Mental Health Therapies

Mesh:

Year:  2004        PMID: 15281414

Source DB:  PubMed          Journal:  J Am Acad Psychiatry Law        ISSN: 1093-6793


  20 in total

1.  Screening for understanding of research in the inpatient psychiatry setting.

Authors:  Norval J Hickman; Judith J Prochaska; Laura B Dunn
Journal:  J Empir Res Hum Res Ethics       Date:  2011-09       Impact factor: 1.742

2.  Capacity to make medical treatment decisions in multiple sclerosis: a potentially remediable deficit.

Authors:  Michael R Basso; Philip J Candilis; Jay Johnson; Courtney Ghormley; Dennis R Combs; Taeh Ward
Journal:  J Clin Exp Neuropsychol       Date:  2010-12       Impact factor: 2.475

3.  Financial capacity in persons with schizophrenia and serious mental illness: clinical and research ethics aspects.

Authors:  Daniel C Marson; Robert Savage; Jacqueline Phillips
Journal:  Schizophr Bull       Date:  2005-11-17       Impact factor: 9.306

Review 4.  Emerging empirical evidence on the ethics of schizophrenia research.

Authors:  Laura B Dunn; Philip J Candilis; Laura Weiss Roberts
Journal:  Schizophr Bull       Date:  2005-10-19       Impact factor: 9.306

5.  Patient-Centered Outcomes Research (PCOR): How Can We Optimize Outcomes in CNS Research?

Authors:  Mitali Wadekar; Anil Sharma; Gina Battaglia
Journal:  Innov Clin Neurosci       Date:  2015 Mar-Apr

6.  The Ethics of Clinical Trials Research in Severe Mood Disorders.

Authors:  Allison C Nugent; Franklin G Miller; Ioline D Henter; Carlos A Zarate
Journal:  Bioethics       Date:  2017-05-15       Impact factor: 1.898

7.  The ethics of research on deep brain stimulation for depression: decisional capacity and therapeutic misconception.

Authors:  Carl Erik Fisher; Laura B Dunn; Paul P Christopher; Paul E Holtzheimer; Yan Leykin; Helen S Mayberg; Sarah H Lisanby; Paul S Appelbaum
Journal:  Ann N Y Acad Sci       Date:  2012-07-19       Impact factor: 5.691

Review 8.  The "Vulnerability" of Psychiatric Research Participants: Why This Research Ethics Concept Needs to Be Revisited.

Authors:  Dearbhail Bracken-Roche; Emily Bell; Eric Racine
Journal:  Can J Psychiatry       Date:  2016-04-05       Impact factor: 4.356

9.  Meta-consent in research on decisional capacity: a "Catch-22"?

Authors:  Elyn R Saks; Laura B Dunn; Barton W Palmer
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

10.  Minority Veterans Are More Willing to Participate in Complex Studies Compared to Non-minorities.

Authors:  Leonardo Tamariz; Irene Kirolos; Fiorella Pendola; Erin N Marcus; Olveen Carrasquillo; Jimmy Rivadeneira; Ana Palacio
Journal:  J Bioeth Inq       Date:  2017-12-19       Impact factor: 1.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.